Introduction

Paediatric ARDS

ARDS is an acute, diffuse (widespread) narrowing of the airways of the lungs, accompanied by lung oedema. It mainly occurs in patients – particularly children – on life support or ventilators due to various respiratory disorders.

Overview of high-frequency oscillatory ventilation (HFOV)

HFOV is an efficient rescue method when mechanical ventilation fails. It prevents lung injury caused by ventilation by lowering volutrauma (an injury caused by overstretching alveoli in the lungs) risks and maintaining sinusoidal (steady) airflow, characterised by constant and low variability in lung pressure.¹

The importance of HFOV application in paediatric ARDS

HFOV is more clinically effective in treating paediatric ARDS, as it provides more oxygen and ventilation, lowers other risk factors, and is regarded as a more clinically appealing method compared to conventional methods.¹

Mechanisms of HFOV

How HFOV works 

1. Small tidal volumes

This method employs small tidal volumes, which are beneficial in reducing barotrauma and volutrauma by minimising alveolar overdistension. It is beneficial in children with ARDS because of their small lung size and high adaptability.¹

2. High respiratory rates

HFOV is known to have high respiratory rates, ranging between 3 and 15 Hz, which helps maintain continuous distension pressure and increases airway volume, leading to improved gas exchange.¹

Benefits of HFOV 

1. Reduction of barotrauma and volutrauma

Barotrauma is caused by excessive pressure which can damage alveoli, causing air to leak out of the lungs. Volutrauma is caused by excess air volume, overextending and overinflating the alveoli, causing inflammation and oedema.⁵ Small tidal volumes used in HFOV are clinically important in lowering barotrauma and volutrauma in the lungs and airways, resulting in lowered lung injury.

2. Improved oxygenation and ventilation

High respiratory rates are clinically more effective in improving oxygenation by expanding the airways. Thus, improving overall ventilation has a positive impact on respiratory disorder complications.

Patient selection criteria

Factors influencing HFOV effectiveness 

1. Age and developmental stage are important factors, as children and geriatric patients are more prone to respiratory disorders like pneumonia and COPD due to impaired immune systems
2. Severity of ARDS impacts HFOV effectiveness as it is mainly helpful against severe complications and failed conventional ventilation
3. Underlying health conditions, including COPD, asthma, bronchitis and pneumonia, that primarily cause ARDS²

Combination therapies

Role of adjunctive treatments 

1. Prone positioning is characterised by lying the patient on their stomach, which increases ventilation, oxygen levels and lowers the associated risks. However, this procedure requires careful consideration and close monitoring of the patient's airway and general safety
2. Medications such as corticosteroids, alongside antibiotics or antiviral,s effectively treat respiratory disorders like pneumonia with severe complications
3. Nitric oxide effectively ventilates airways and treats the symptomatic complications of ARDS²

Potential benefits of multimodal approaches

Multimodal approaches target ARDS complications through personalised pharmaceutical and non-pharmaceutical treatments, while also improving the quality of life with achievable results within a specified time period.³

Technological advances

Innovations in HFOV ventilators include:

• Improved waveform delivery
• Integrated monitoring systems
• User-friendly interfaces
• Enhanced alarms and alerts
• Compatibility with other therapies

Impact of monitoring technologies on patient outcomes includes:

• Real-time data collection
• Early detection of complications
• Reduction in ventilator-associated complications

Future directions in HFOV technology include:

• Personalised ventilation strategies
• Biomarker integration
• Expanded applications
• Portable HFOV devices
• Enhanced safety features

Global perspective

Variability in HFOV access and expertise 

• Economic constraints lead to disparity in the availability of these innovative devices, particularly in underdeveloped countries
• Secondly, specialised training and expertise are required to operate and manage these devices

Case studies from different regions 

Case studies on HFOV are more pronounced and comprehensive in developed countries, as compared to those from underdeveloped countries like Pakistan.⁴ 

Long-term outcomes

• HFOV has a crucial impact on lung development, airway expansion, and overall lung health and functioning
• Quality of life considerations and palliative care are prioritised for paediatric ARDS survivors to improve overall health outcomes⁴

Family-centered care

• Including families in the care process significantly impacts the overall quality of life as it builds confidence and reduces social anxiety and other negative factors
• Psychological and emotional support for caregivers is also a crucial factor in family-centred care, as it focuses on symptomatic and psychological aspects of the ailment

Training and implementation

• The proper training of healthcare providers and caregivers is crucial for dealing with and treating patients with ARDS
• Educational programs and resources are needed for the training and counselling of healthcare providers, families, and patients
• HFOV implementation in clinical settings poses challenges, including resource availability, low literacy rates, communication gaps and improper training of caregivers

Future directions and personalised medicine

• It includes implementing new and innovative procedures and techniques, with research focusing on proper analysis and prognosis of biomarkers for response to HFOV
• There is great potential for personalised treatment approaches based on patient needs and characteristics such as age, gender, severity and medical history

FAQs

What is High-Frequency Oscillatory Ventilation (HFOV)?

HFOV is a mechanical ventilation mode that delivers small tidal volumes at high frequencies (up to 900 breaths per minute) to improve gas exchange while minimising lung injury.

How does HFOV differ from conventional mechanical ventilation?

Unlike conventional ventilation, which uses larger tidal volumes and lower respiratory rates, HFOV utilises small tidal volumes and high frequencies, reducing the risk of barotrauma and volutrauma.

Who are the ideal candidates for HFOV?

Ideal candidates include paediatric patients with moderate to severe ARDS, especially those not responding well to conventional ventilation or those at high risk for lung injury.

What are the main benefits of using HFOV?

Benefits include reduced risk of lung injury, improved oxygenation and ventilation, and better recruitment of collapsed alveoli, which can enhance overall lung function.

Are there any risks or complications associated with HFOV?

Potential risks include airway obstruction, sedation-related complications, and potential hemodynamic instability due to the use of positive pressure. Close monitoring is essential to mitigate these risks.

How does HFOV improve oxygenation?

HFOV maintains continuous positive airway pressure, which keeps the alveoli open and enhances ventilation-perfusion matching, thereby improving oxygen uptake.

Can HFOV be used in combination with other treatments?

Yes, HFOV can be combined with adjunctive therapies such as prone positioning, corticosteroids, and inhaled nitric oxide to optimise outcomes for patients with ARDS.

Summary

ARDS is one of the most important aspects of paediatric specialisation in medicine, pharmacology, and nursing, due to its high prevalence and associated casualties. Therefore, proper training and educational programs are highly beneficial. Complex treatment plans, particularly those involving steroids, should be implemented under appropriate guidelines and supervision of highly specialised health care teams.